Articles by Leah Lawrence
We spoke with several researchers involved in exploring the clinical utility of liquid biopsy for genitourinary cancers.
We spoke with clinicians about some of the disparities that exist, why they persist, and what might be done to correct them.
Testicular cancer experts discuss current practices and challenges related to staging, treatment, and survivorship.
Several urologists weigh in on BCG, its role in NMIBC treatment, shortages, and strategies to treat BCG-unresponsive disease.
Several experts discuss the evolution of nephrectomy, how it is used today, which patients are best suited for it, and more.
Several physicians highlight the newest data on radiation for metastatic prostate cancer and its role moving forward.
Nivolumab plus ipilimumab showed “modest clinical efficacy” in patients with nccRCC in a study of real-world data from ...
5-ARIs, used in the treatment of benign prostatic hyperplasia and androgenic alopecia, may be associated with depression.
The incidence and mortality from kidney cancer increased from 1990-2019 across most of the EU 15+ countries and WHO regions.
Care cascade after receipt of a low-value PSA testing occurred commonly among veterans enrolled in both the VHA and Medicare.
The IRONMAN registry has enrolled an international cohort of patients with newly diagnosed prostate cancer.
A genetic testing model for prostate cancer patients boosted testing compliance and decreased turnaround time for results.
Endoscopic balloon cryoablation is an effective therapy for transurethral resection of non-muscle invasive bladder cancer.
Researchers developed a prostate cancer model with high discrimination and good calibration for predicting incident disease.
A delay in definitive radical cystectomy or radical nephro-ureterectomy is associated with poor survival in UTUC patients.
Screening using an MRI-directed targeted biopsy in men with an elevated PSA level reduced the risk for overdiagnosis by half.
The results also showed a 46% best overall response rate in the study’s intention-to-treat population.
Cryoablation and heat-based thermal ablation represent alternative management options for frail and/or comorbid RCC patients.
Two studies emphasize the need for ethnically diverse prostate cancer genomics data and accessible genetic testing.
An analysis of enrollment incidence ratios revealed that Black & Hispanic patients were both underrepresented in U.S. trials.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.